EXAMINE THIS REPORT ON HEMGENIX

Range of suitable clients: CDEC talked over the uncertainty in the volume of clients with moderately significant to significant hemophilia B in Canada qualified for etranacogene dezaparvovec. Clinical specialists consulted by CADTH indicated that some patients who will be labeled as obtaining gentle or moderate sickness could have a severe bleeding